Uncategorized
Study of SPK-RPE65 gene therapy shows gains in visual acuity
LAS VEGAS — SPK-RPE65 treatment may result in rapid postoperative recovery of visual acuity for RPE65-mediated inherited retinal dystrophies, according to a presentation here. Albert M. Maguire, MD, discussed the phase 3 study’s primary and secondary endpoints, and presented additional results for the gene therapy at the American Academy of Ophthalmology annual meeting.